Epidemiological and molecular aspects of ovarian cancer risk.
about
Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer.External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomasEstrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.Epidemiological and genetic factors associated with ovarian cancer.Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice.Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinomaOvarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms.Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapySerum CA125 concentration has inverse correlation with metabolic syndrome.Autoantibodies to mesothelin in infertility.TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival.Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.Epithelial ovarian cancer stem cells-a review.Risk of other cancers in individuals with a family history of pancreas cancerHistopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer.Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes.Determination of serum CRP, VEGF, Leptin, CK-MB, CA-15-3 and IL-6 levels for malignancy prediction in adnexal masses.Risks and benefits of dietary isoflavones for cancer.Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc.The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer.Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.All-cause mortality and cancer incidence among adults exposed to blue asbestos during childhood.Association between late age at infectious mononucleosis, Epstein-Barr virus antibodies, and ovarian cancer risk.A comparison of the cyclic variation in serum levels of CA125 across the menstrual cycle using two commercial assays.Ethnic differences in survival among women with ovarian carcinoma.The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer.Correlation Between Immunohistochemical Biomarkers Expression and Prognosis of Ovarian Carcinomas in Tunisian Patients.Nodal status--its impact on prognosis in advanced ovarian cancer.EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
P2860
Q31002489-0DEA49A4-E6F4-4C20-8461-B8FC46BB92B8Q33506176-F557EF24-DA0A-43BC-877B-04614EEEBC1BQ33642747-026C487D-CEA9-4E3F-BFA4-2548967CAFB6Q33768557-7FA947AA-0752-4778-B2E9-4EB9DEA25E5AQ33936537-CD777BF9-916F-4133-B1DD-A3298897CC0AQ34119623-35EFB40D-31E7-486D-B1CC-77327FC0FA2BQ34508726-76D7987E-D06D-4A0C-9281-90A57B871C1DQ34714707-AD4A6F0F-AE01-439C-9440-D06937036567Q34893763-3FA663E0-0105-4751-A8BF-947A61165F58Q35060014-C6279C0C-D4C5-4A6F-A5AB-69E1388DF065Q35333807-E5DB9207-B8A9-4687-AA44-40B74B33BE23Q35832948-84FB1F8C-F256-4F91-93A0-B9CFCD93AFB7Q35853937-80ECEEB0-7262-4E43-A773-CA47C360182DQ36075250-80222298-C7A8-43E8-9A03-D436FFB689FEQ36663567-318D9A28-910A-4555-B885-19452249C3C0Q36992785-D9F8C6CC-0321-4F36-ABB2-D3AE01AEB4E1Q37284983-3DB7985E-47B3-4B88-8450-F9F3D31F61C5Q37381736-254FF2EF-A904-4533-98B5-AA48C04B14B3Q37424014-ABC83564-8026-4AD2-920C-5CAB190EFF68Q37611320-FFAEE9A1-9F46-484C-884A-4C05D4509716Q37857841-158D6142-71C1-40A9-802B-673FC5A5D867Q38939084-6157C078-3D8F-4668-91DC-E8CE3909E18DQ41615167-68B287BF-AD80-4CBE-9BC6-C4EA85C38CEDQ43864805-04BF06DE-7476-4AA9-91F4-C4C211F459DAQ45393968-11F0ADD0-8332-4160-BB3C-4057CA2F2BEFQ45710453-59315A59-4766-49D9-A9EC-D1469B48678BQ46035706-CE05690B-3C84-490C-96C3-EF07C2F06FA1Q46213210-85902392-8B52-4255-9B65-331EFD3AB1FCQ46323741-FA62B045-EDC5-4E9D-A1AB-7FE8B69E4D94Q47132946-A15C9012-4CB1-48C1-8458-7A9CC241BD70Q50991654-E4F7BD1E-1A24-43CB-8806-E41B33473288Q54417851-28079942-F0C9-4A07-A1A8-3F4E848B3A77Q58423073-65FCC289-7726-4BB3-93B2-2C34FE629094
P2860
Epidemiological and molecular aspects of ovarian cancer risk.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Epidemiological and molecular aspects of ovarian cancer risk.
@ast
Epidemiological and molecular aspects of ovarian cancer risk.
@en
Epidemiological and molecular aspects of ovarian cancer risk.
@nl
type
label
Epidemiological and molecular aspects of ovarian cancer risk.
@ast
Epidemiological and molecular aspects of ovarian cancer risk.
@en
Epidemiological and molecular aspects of ovarian cancer risk.
@nl
prefLabel
Epidemiological and molecular aspects of ovarian cancer risk.
@ast
Epidemiological and molecular aspects of ovarian cancer risk.
@en
Epidemiological and molecular aspects of ovarian cancer risk.
@nl
P356
P1476
Epidemiological and molecular aspects of ovarian cancer risk.
@en
P2093
E Stickeler
I B Runnebaum
P2888
P356
10.1007/S004320000153
P577
2001-02-01T00:00:00Z